v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (5,843) $ (1,276)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 382 1
Stock-based compensation 107
Noncash interest expense 134 67
Issuance cost allocated to warrant liability 1,088
Change in fair value of warrant liability (1,410)
Changes in operating assets and liabilities:    
Trade receivable 15 (171)
Other accounts receivable and prepaid expenses (216) (142)
Inventory 380 301
Trade payables 99 (46)
Other accounts payable and accrued expenses 656 51
Deferred revenue (15) (23)
Change in operating lease liabilities, net 1
Accrued severance pay, net 3 (1)
Net cash used in operating activities (4,726) (1,132)
Cash flows from investing activities:    
Cash acquired in ENvue Merger 148
Purchases of property and equipment (9) (3)
Net cash provided by (used in) investing activities 139 (3)
Cash flows from financing activities:    
Proceeds from the issuance of preferred stock and warrants, net 8,215
Proceeds from issuance of convertible note payable from related party 1,300
Payments of note payable to related party (1,300)
Payments of short-term loans to related party (777)  
Proceeds from issuance of short-term loan payable 360
Proceeds from exercise of options and warrants 102 28
Net cash provided by financing activities 7,900 28
Effects of currency translation on cash, cash equivalents and restricted cash (5) (6)
Net (decrease) increase in cash, cash equivalents and restricted cash 3,308 (1,113)
Cash, cash equivalents and restricted cash at beginning of period 752 3,283
Cash, cash equivalents and restricted cash at end of period 4,060 2,170
Cash and cash equivalents 4,030 2,170
Restricted cash at end of period 30
Total cash, cash equivalents and restricted cash 4,060 2,170
Supplemental disclosures of cash flow information:    
Cash paid for interest $ 25